Method for graphically depicting drug adverse effect risks

• US 20090158211A1
• Filed: 05/02/2001
• Published: 06/18/2009
• Est. Priority Date: 05/02/2001
• Status: Active Grant

• Current Assignee: Druglogic Incorporated
• Original Assignee: Victor V. Gogolak
• Inventors: Gogolak, Victor V.
• Granted Patent: US 7,925,612 B2
• Time in Patent Office: Days
• US Class Current: 715/811
• CPC Class Codes: G16H 50/30 for calculating health indices; for individual health risk assessment
• CPC Class Codes: G16H 50/70 for mining of medical data, e.g. analysing previous cases of other patients
• CPC Class Codes: G16H 70/40 relating to drugs, e.g. their side effects or intended usage
• CPC Class Codes: Y10S 706/924 Medical

Abstract

The present invention pertains to an enhanced method for displaying assessment and analysis of the risks of adverse effects resulting from the use of at least one substance of interest, comprising: identifying the at least one substance of interest; selecting the profile of the at least one substance of interest related to the safety of the at least one substance of interest, using at least one filter; analyzing the risks of adverse effects resulting from the use of the at least one substance of interest using at least one data mining engine; and displaying the results of the analysis of risks of adverse effects resulting from the use of the at least one substance of interest in a format that permits perception of correlations. Such a format is preferably at least one format selected from the group consisting of a radar display for display of correlations, a sortable table, and a sortable line listing and where the format contains elements linked to data regarding the adverse effects.

Claims

1. A method for displaying assessment and analysis of the risks of adverse effects resulting from the use of at least one substance of interest, comprising:

identifying the at least one substance of interest;

selecting the profile of the at least one substance of interest related to the safety of the at least one substance of interest, using at least one filter;

analyzing the risks of adverse effects resulting from the use of the at least one substance of interest using at least one data mining engine; and

displaying the results of the analysis of risks of adverse effects resulting from the use of the at least one substance of interest in a format that permits perception of correlations.

2. The method for displaying assessment and analysis of the risks of adverse effects resulting from the use of at least one substance of interest according to claim 1, wherein the format is at least one format selected from the group consisting of a radar display for display of correlations, a sortable table, and a sortable line listing.

3. The method for displaying assessment and analysis of the risks of adverse effects resulting from the use of at least one substance of interest according to claim 2, wherein the at least one data mining engine is a proportional analysis engine to assess deviations in a set of the reactions to the at least one substance of interest.

4. The method for displaying assessment and analysis of the risks of adverse effects resulting from the use of at least one substance of interest according to claim 2, wherein the at least one data mining engine is a comparator to measure the reactions to the at least one substance of interest against a user-defined backdrop.

5. The method for displaying assessment and analysis of the risks of adverse effects resulting from the use of at least one substance of interest according to claim 2, wherein the at least one data mining engine is a correlator to look for correlated signal characteristics in drug/reaction/demographic information.

6. The method for displaying assessment and analysis of the risks of adverse effects resulting from the use of at least one substance of interest according to claim 2, wherein the data mining engine is at least two members of the group consisting of a proportional analysis engine, a comparator, and a correlator.

7. The method for displaying assessment and analysis of the risks of adverse effects resulting from the use of at least one substance of interest according to claim 2, wherein the at least one substance of interest is assessed in combination with other drugs, foodstuffs, beverages, nutrients, vitamins, toxins, chemicals, hormones, and supplements.

8. The method for displaying assessment and analysis of the risks of adverse effects resulting from the use of at least one substance of interest according to claim 2, wherein the method permits assessment and analysis of the risks of adverse effects resulting from the use of at least one drug of interest in any of multiple dimensions of the risk assessment and analysis.

9. The method for displaying assessment and analysis of the risks of adverse effects resulting from the use of at least one substance of interest according to claim 2, wherein the format is a radar display for display of correlations.

10. The method for displaying assessment and analysis of the risks of adverse effects resulting from the use of at least one substance of interest according to claim 9, wherein the radar display contains elements linked to data regarding the adverse effects.

11. The method for displaying assessment and analysis of the risks of adverse effects resulting from the use of at least one substance of interest according to claim 2, wherein the format is a sortable table.

12. The method for displaying assessment and analysis of the risks of adverse effects resulting from the use of at least one substance of interest according to claim 11, wherein the sortable table contains elements linked to data regarding the adverse effects.

13. The method for displaying assessment and analysis of the risks of adverse effects resulting from the use of at least one substance of interest according to claim 2, wherein the format is a sortable line listing.

14. The method for displaying assessment and analysis of the risks of adverse effects resulting from the use of at least one substance of interest according to claim 13, wherein the sortable line listing contains elements linked to data regarding the adverse effects.

16. The method for displaying assessment and analysis of the risks of adverse effects resulting from the use of at least one drug of interest according to claim 1, wherein the format is at least one format selected from the group consisting of a radar display for display of correlations, a sortable table, and a sortable line listing.

17. The method for displaying assessment and analysis of the risks of adverse effects resulting from the use of at least one drug of interest according to claim 16, wherein the at least one data mining engine is a proportional analysis engine to assess deviations in a set of the reactions to the at least one drug of interest.

18. The method for displaying assessment and analysis of the risks of adverse effects resulting from the use of at least one drug of interest according to claim 16, wherein the at least one data mining engine is a comparator to measure the reactions to the at least one drug of interest against a user-defined backdrop.

19. The method for displaying assessment and analysis of the risks of adverse effects resulting from the use of at least one drug of interest according to claim 16, wherein the at least one data mining engine is a correlator to look for correlated signal characteristics in drug/reaction/demographic information.

20. The method for displaying assessment and analysis of the risks of adverse effects resulting from the use of at least one drug of interest according to claim 16, wherein the data mining engine is at least two members of the group consisting of a proportional analysis engine, a comparator, and a correlator.

21. The method for displaying assessment and analysis of the risks of adverse effects resulting from the use of at least one drug of interest according to claim 16, wherein the at least one drug of interest is assessed in combination with other drugs, foodstuffs, beverages, nutrients, vitamins, toxins, chemicals, hormones, and supplements.

22. The method for displaying assessment and analysis of the risks of adverse effects resulting from the use of at least one drug of interest according to claim 16, wherein the method permits assessment and analysis of the risks of adverse effects resulting from the use of at least one drug of interest in any of multiple dimensions of the risk assessment and analysis.

23. The method for displaying assessment and analysis of the risks of adverse effects resulting from the use of at least one drug of interest according to claim 16, wherein the format is a radar display for display of correlations.

24. The method for displaying assessment and analysis of the risks of adverse effects resulting from the use of at least one drug of interest according to claim 23, wherein the radar display contains elements linked to data regarding the adverse effects.

25. The method for displaying assessment and analysis of the risks of adverse effects resulting from the use of at least one drug of interest according to claim 16, wherein the format is a sortable table.

26. The method for displaying assessment and analysis of the risks of adverse effects resulting from the use of at least one drug of interest according to claim 25, wherein the sortable table contains elements linked to data regarding the adverse effects.

27. The method for displaying assessment and analysis of the risks of adverse effects resulting from the use of at least one drug of interest according to claim 16, wherein the format is a sortable line listing.

28. The method for displaying assessment and analysis of the risks of adverse effects resulting from the use of at least one drug of interest according to claim 27, wherein the sortable line listing contains elements linked to data regarding the adverse effects.

15. A method for displaying assessment and analysis of the risks of adverse effects resulting from the use of at least one drug of interest, comprising:

identifying the at least one drug of interest;

selecting the profile of the at least one drug of interest related to the safety of the at least one drug of interest, using at least one filter;

analyzing the risks of adverse effects resulting from the use of the at least one drug of interest using at least one data mining engine; and

displaying the results of the analysis of risks of adverse effects resulting from the use of the at least one drug of interest in a format that permits perception of correlations.